ORMP - ORAMED PHARMACEUTICALS INC.
3.62
0.240 6.630%
Share volume: 163,978
Last Updated: 03-04-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.72%
PREVIOUS CLOSE
CHG
CHG%
$3.38
0.24
0.07%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
| Report Date | 05-09-2024 | 08-14-2024 | 11-07-2024 | 03-27-2025 | 05-15-2025 | 08-14-2025 | 11-13-2025 | |
| Cash flow financing | -19.000 M | -30.550 M | -1.291 M | -1.195 M | 0.000 | -371.000 K | -361.000 K | |
| Other financing cash flows | 0.000 | 0.000 | 0.000 | -2.000 K | 0.000 | 0.000 | 0.000 | |
| Cash flow | 9.522 M | 66.181 M | -42.652 M | 12.318 M | 20.097 M | -58.759 M | 36.378 M | |
| Net income | 1.534 M | 9.204 M | -19.642 M | -10.156 M | -7.642 M | 13.260 M | 48.389 M | |
| Depreciation | 56.000 K | 54.000 K | 52.000 K | 31.000 K | 30.000 K | 30.000 K | 31.000 K | |
| Changes in inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Changes in receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | 29.998 M | 94.655 M | -34.260 M | 15.424 M | 23.616 M | -54.853 M | 38.364 M | |
| Net Borrowings | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Activity Other | 0.000 | 0.000 | 3.502 M | -65.000 K | 2.736 M | -66.557 M | -746.000 K | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | 2.000 K | 0.000 | 5.000 K | 11.000 K | 3.000 K | 4.000 K | 0.000 | |
| Cash Change | 9.521 M | 66.177 M | -42.649 M | 12.316 M | 20.096 M | -58.719 M | 36.339 M |